Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the long-term safety and tolerability profile of
valsartan and valsartan-based treatments in children with hypertension, with or without
chronic kidney disease.